(marketscreener.com) Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Good Therapeutics Inc. Distributed Bio will use its proprietary SuperHuman antibody library platform to discover therapeutic ready...http://www.marketscreener.com/news/Distributed-Bio-Inc-and-Good-Therapeutics-Inc-Announce-Multi-Target-Collaboration--27742101/?utm_medium=RSS&utm_content=20181212
Distributed Bio develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions.